Vitamins A, B, C, D, E, F, trace elements and heavy metals: Unapproved uses or indications

Clinics in Dermatology

Volumn 18, Issue 1, 2000, Pages 87-94

  Nicolaidou, Electra ^a   Katsambas, Andreas D ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; HEAVY METAL; RETINOL; SELENIUM; TRACE ELEMENT; VITAMIN B GROUP; VITAMIN D; ZINC;

ACNE; DERMATITIS; DYSKERATOSIS; HUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN CANCER; TREATMENT INDICATION; WOUND HEALING;

DERMATOLOGIC AGENTS; DRUG APPROVAL; DRUG UTILIZATION; HUMANS; METALS, HEAVY; SKIN DISEASES; TRACE ELEMENTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VITAMINS;

EID: 0033964880     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(99)00097-8     Document Type: Review

References (94)

1. Li V.W., Jaffe M.P., Li Ww, et al. Off-label dermatologic therapies. Arch Dermatol. 134:1998;1449-1454.
2. Physicians' desk reference. 52nd ed. Montvale, NJ: Medical Economics, 1998:1-1395.
3. Miller S.J. Nutritional deficiency and the skin. J Am Acad Dermatol. 21:1989;1-30.
4. Kligman A.M., Fulton J.E., Plewig G. Topical vitamin A acid in acne vulgaris. Arch Dermatol. 99:1969;469-476.
5. Kligman A.M. The growing importance of topical retinoids in clinical dermatology A retrospective and prospective analysis . J Am Acad Dermatol. 39:1998;S2-S7.
6. Hunt T.K. Vitamin A and wound healing. J Am Acad Dermatol. 15:1986;817-821.
7. Brandaleone H., Papper E. The effect of the local and oral administration of cod liver oil on the rate of wound healing in vitamin A deficient and normal animals. Ann Surg. 114:1941;791-798.
8. Ehrlich H.P., Hunt T.K. Effects of cortisone and vitamin A on wound healing. Ann Surg. 167:1968;324-328.
9. Gruber C., Kan D., Levenson S.M., et al. Influence of vitamin A on wound healing in rats with femoral fracture. Ann Surg. 181:1975;836-841.
10. Weinzweig J., Levenson S.M., Rettura G., et al. Supplemental vitamin A prevents the tumor-induced defect in wound healing. Ann Surg. 221:1990;269-276.
11. Levenson S.M., Gruber C.A., Rettura G., et al. Supplemental vitamin A prevents the acute radiation-induced defect in wound healing. Ann Surg. 200:1984;494-512.
12. Rackett S.C., Rothe M.J., Grant-Kels J.M. Diet and dermatology. J Am Acad Dermatol. 29:1993;447-461.
13. Levenson S.M., Demetriou A.A. Metabolic factors. Cohen I.K., Diegelmann R.F., Lindblad W.J. Wound healing Biochemical and clinical aspects . 1992;248-273 Saunders, Philadelphia.
14. Elson M.L. The role of retinoids in wound healing. J Am Acad Dermatol. 39:1998;S79-S81.
15. Mandy S. Tretinoin in the preoperative and postoperative management of dermabrasion. J Am Acad Dermatol 1986;15:878-9, 888-9.
16. Hevia O., Nemeth A.J., Taylor J.R. Tretinoin accelerates healing after trichloracetic acid chemical peel. Arch Dermatol. 127:1991;678-682.
17. Apfelberg D.B. Ultrapulse carbon dioxide laser with CPG scanner for full-face resurfacing for rhytids, photoaging, and acne scars. Plast Reconstr Surg. 99:1997;1817-1825.
18. Elson M.L. Treatment of striae distensae with topical tretinoin. J Dermatol Surg Oncol. 16:1990;267-270.
19. Kang S., Kim K.J., Griffiths C.E., et al. Topical tretinoin (retinoic acid) improves early stretch marks. Arch Dermatol. 132:1996;519-526.
20. Thomas J.R. 3rd, Cooke J.P., Winkelmann R.K. High-dose vitamin A therapy for Darier's disease. Arch Dermatol. 118:1982;891-894.
21. Aram H., Even-Paz Z., Livshin R. Kyrle's disease Response to high-dose vitamin A . Cutis. 30:1982;753-755.
22. Hay R.J., Champion R.H., Greaves M.W. Systemic therapy. Champion R.H., Burton J.L., Ebling F.J.G. Textbook of dermatology. 1992;2927-2960 Blackwell Scientific Publications, Oxford.
23. Saurat J.H. Retinoids. Katsambas A.D., Lotti T.M. European handbook of dermatologic treatments. 1999;812-818 Springer-Verlag, Berlin, Heidelberg.
24. Fritsch PO. Retinoids in psoriasis and disorders of keratinization. J Am Acad Dermatol 1992;27:S8-14.
25. Goldsmith LA, Weinrich AE, Shupack J. Pityriasis rubra pilaris response to 13-cis-retinoic acid (isotretinoin). J Am Acad Dermatol 1982;6(Suppl):710-5.
26. Griffiths W.A.D. Pityriasis rubra pilaris. Katsambas A.D., Lotti T.M. European handbook of dermatologic treatments. 1999;453-458 Springer-Verlag, Berlin, Heidelberg.
27. Levine N. Role of retinoids in skin cancer treatment and prevention. J Am Acad Dermatol. 39:1998;S62-S66.
28. Haydey R.P., Reed M.L., Dzubow L.M., et al. Treatment of keratoacanthomas with oral 13-cis-retinoic acid. N Engl J Med. 303:1980;560-562.
29. Benoldi D., Alinovi A. Multiple persistent keratoacanthomas Treatment with oral etretinate . J Am Acad Dermatol. 10:1984;1035-1038.
30. Lippman S.M., Meyskens F.L. Jr. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med. 107:1987;499-502.
31. Kraemer K.H., DiGiovanna J.J., Moshell A.N., et al. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med. 318:1998;1633-1637.
32. Goldberg L.H., Hsu S.H., Alcalay J. Effectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndrome. J Am Acad Dermatol. 21:1989;144-145.
33. DiGiovanna J.J. Retinoid chemoprevention in the high-risk patient. J Am Acad Dermatol. 39:1998;S82-S85.
34. Moon T.E., Levine N., Cartmel B., et al. Effect of retinol to prevent squamous cell skin cancer in moderate-risk subjects. Cancer Epidemiol Biomarkers Prev. 6:1997;949-956.
35. Levine N., Moon T.E., Cartmel B., et al. Trial of retinol and isotretinoin in skin cancer prevention. Cancer Epidemiol Biomarkers Prev. 6:1997;957-961.
36. Katsambas A.D., Lotti T.M. Melasma. Katsambas A.D., Lotti T.M. European handbook of dermatologic treatments. 1999;368-373 Springer-Verlag, Berlin, Heidelberg.
37. Laszlo Keller K., Fenske N.A. Uses of vitamins A, C, and E and related compounds in dermatology A review . J Am Acad Dermatol. 39:1998;611-625.
38. Parish L.C., Sofman M.S., Chalker D.K. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol. 34:1995;434-437.
39. Handfield-Jones S., Jones S., Peachey R. High-dose nicotinamide in the treatment of necrobiosis lipoidica. Br J Dermatol. 118:1988;693-696.
40. Zemtsov A., Neldner K.H. Successful treatment of dermatitis herpetiformis with tetracycline and nicotinamide in a patient unable to tolerate dapsone. J Am Acad Dermatol. 28:1993;505-506.
41. Fivenson D.P., Breneman D.L., Rosen G.B., et al. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol. 130:1994;753-758.
42. Ross J.B., Moss M.A. Relief of the photosensitivity of erythropoietic protoporphyria by pyridoxine. J Am Acad Dermatol. 22:1990;340-342.
43. 12 and folic acid and the importance of sun exposure. Acta Derm Venereol (Stockh). 77:1997;460-462.
44. Darr D., Combs S., Dunston S., et al. Topical vitamin C protects porcine skin from ultraviolet radiation-induced damage. Br J Dermatol. 127:1992;247-253.
45. Darr D., Dunston S., Faust H., et al. Effectiveness of antioxidants (vitamin C and E) with and without sunscreens as topical photoprotectants. Acta Derm Venereol (Stockh). 76:1996;264-268.
46. Eberlein-Konig B., Placzek M., Przybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E). J Am Acad Dermatol. 38:1998;45-48.
47. Dunham W.B., Zuckerkandl E., Reynolds R., et al. Effects of intake of L-ascorbic acid on the incidence of dermal neoplasms induced in mice by ultraviolet light. Proc Natl Acad Sci U S A. 79:1982;7532-7536.
48. Pauling L. Effect of ascorbic acid on incidence of spontaneous mammary tumors and UV-light-induced skin tumors in mice. Am J Clin Nutr. 546:((Suppl)):1991;S1252-S1255.
49. Van de Kerkhof P.C.M. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br J Dermatol. 132:1995;675-682.
50. 3 and skin diseases. Arch Dermatol Res 1992;284(Suppl 1):S30-6.
51. Kragballe K. The future of vitamin D in dermatology. J Am Acad Dermatol. 37:1997;S72-S76.
52. Kienbaum S, Lehmann P, Ruzicka T. Topical calcipotriol in the treatment of intertriginous psoriasis (abstract). J Invest Dermatol Symp Proc 1996;1:112.
53. Berth-Jones J., Bourke J., Bailey K., et al. Generalized pustular psoriasis Response to topical calcipotriol . Br Med J. 305:1992;868-869.
54. Kokelj F., Lavaroni G., Piraccini B.M., et al. Nail psoriasis treated with calcipotriol (MC 903) An open study . J Dermatol Treat. 5:1994;149-150.
55. Gray J.D., Bottomley W., Layton A.M., et al. The use of calcipotriol in HIV-related psoriasis. Clin Exp Dermatol. 17:1992;342-343.
56. Kragballe K., Steijlen P.M., Henning Ibsen H., et al. Efficacy, tolerability and safety of calcipotriol ointment in disorders of keratinization. Arch Dermatol. 131:1995;556-560.
57. Lucker G.P., van de Kerkhof P.C., Cruysberg J.R., et al. Topical treatment of Sjogren-Larsson syndrome with calcipotriol. Dermatology. 190:1995;292-294.
58. Van de Kerkhof P.C., Steijlen P.M. Topical treatment of pityriasis rubra pilaris with calcipotriol. Br J Dermatol. 130:1994;675-678.
59. Mota A.V., Correia T.M., Lopes J.M., et al. Successful treatment of Grover's disease with calcipotriol. Eur J Dermatol. 8:1998;33-35.
60. Harrison P.V., Stollery N. Disseminated superficial actinic porokeratosis responding to calcipotriol (letter). Clin Exp Dermatol. 19:1994;95.
61. Parsad D., Saini R., Verma N. Combination of PUVA and topical calcipotriol in vitiligo. Dermatology. 197:1998;167-170.
62. Bower M., Colston K.W., Stein R.C., et al. Topical calcipotriol treatment in advanced breast cancer. Lancet. 337:1991;701-702.
63. Thiers B.H. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis. J Am Acad Dermatol. 37:1997;S69-S71.
64. McVean M., Liebler D.C. Inhibition of UVB-induced DNA photodamage in mouse epidermis by topically applied alpha-tocopherol. Carcinogenesis. 18:1997;1617-1622.
65. Trevithick J.R., Xiong H., Lee S., et al. Topical tocopherol acetate reduces post-UVB sunburn-associated erythema, edema, and skin sensitivity in hairless mice. Arch Biochem Biophys. 296:1992;575-582.
66. Bissett D.L., Chatterjee R., Hannon D.P. Photoprotective effect of superoxide-scavenging antioxidants against ultraviolet radiation-induced chronic skin damage in the hairless mouse. Photodermatol Photoimmunol Photomed. 7:1990;56-62.
67. Werninghaus K., Meydani M., Bhawan J., et al. Evaluation of the photoprotective effect of oral vitamin E supplementation. Arch Dermatol. 130:1994;1257-1261.
68. Burg G. Disseminated granuloma anulare Therapy with vitamin E topically . Dermatology. 184:1992;308-309.
69. Williams H.C., Buffham R., du Vivier A. Successful use of topical vitamin E solution in the treatment of nail changes in yellow nail syndrome. Arch Dermatol. 127:1991;1023-1028.
70. Ayres S Jr, Mihan R. Lupus erythematosus and vitamin E: An effective and non-toxic therapy. Cutis 1979;23:49-52, 54.
71. Yell J.A., Burge S., Wojnarowska F. Vitamin E and discoid lupus erythematosus. Lupus. 1:1992;303-305.
72. Manku M.S., Horrobin D.F., Morse N.L., et al. Essential fatty acids in the plasma phospholipids of patients with atopic eczema. Br J Dermatol. 110:1984;643-648.
73. Morse P.F., Horrobin D.F., Manku M.S., et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema Relationship between plasma essential fatty acid changes and clinical response . Br J Dermatol. 121:1989;75-90.
74. Berth-Jones J., Graham-Brown R.A. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet. 341:1993;1557-1560.
75. Borrek S., Hildebrandt A., Forster J. Gamma-linolenic-acid-rich borage seed oil capsules in children with atopic dermatitis A placebo-controlled double-blind study . Klin Padiatr. 209:1997;100-104.
76. Whitaker D.K., Cilliers J., de Beer C. Evening primrose oil (Epogam) in the treatment of chronic hand dermatitis Disappointing therapeutic results . Dermatology. 193:1996;115-120.
77. Ramesh G, Das UN. Effect of evening primrose and fish oils on two-stage skin carcinogenesis in mice. Prostaglandins Leukot Essent Fatty Acids 1998;59:155-61.
78. Yoshimoto-Furuie K., Yoshimoto K., Tanaka T., et al. Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients. Nephron. 81:1999;151-159.
79. Dreno B., Amblard P., Agache P., et al. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol. 69:1989;541-543.
80. Burrows N.P., Turnbull A.J., Punchard N.A., et al. A trial of oral zinc supplementation in psoriasis. Cutis. 54:1994;117-118.
81. Crutchfield C.E. 3rd, Lewis E.J., Zelickson B.D. The highly effective use of topical zinc pyrithione in the treatment of psoriasis A case report . Dermatol Online J. 3:1997;3.
82. Agren M.S. Studies on zinc in wound healing. Acta Derm Venereol. 154:1990;1-36.
83. Kalish R.S., Wood J.A., Siegel D.M., et al. Experimental rationale for treatment of high-risk human melanoma with zinc chloride fixative paste Increased resistance to tumor challenge in murine melanoma model . Dermatol Surg. 24:1998;1021-1025.
84. Pence B.C., Delver E., Dunn D.M. Effects of dietary selenium of UVB-induced skin carcinogenesis and epidermal antioxidant status. J Invest Dermatol. 102:1994;759-761.
85. Whanger P.D. Selenium in the treatment of heavy metal poisoning and chemical carcinogenesis. J Trace Elem Electrolytes Health Dis. 6:1992;209-221.
86. Clark L.C., Graham G.F., Crounse R.G., et al. Plasma selenium and skin neoplasms A case control study . Nutr Cancer. 6:1984;13-21.
87. Combs G.F. Jr, Clark L.C., Turnbull B.W., et al. Low plasma selenium predicts the 24-month incidence of squamous cell carcinoma of the skin in a cancer prevention trial. FASEB J. 7:1993;A278.
88. Clark L.C., Combs G.F. Jr, Turnbull B.W., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin A randomized controlled trial . Nutritional Prevention of Cancer Study Group. JAMA. 276:1996;1957-1963.
89. Weismann K. Neurosyphilis, or chronic heavy metal poisoning Karen Blixen's lifelong disease . Sex Transm Dis. 22:1995;137-144.
90. Farber E.M. History of the treatment of psoriasis. J Am Acad Dermatol. 27:1992;640-645.
91. Thorburn A.L. Paul Ehrlich Pioneer of chemotherapy and cure by arsenic (1854-1915) . Br J Vener Dis. 59:1983;404-405.
92. Canuel C., Krulik M., Audebert A.A., et al. Erythroderma and leukoneutropenia induced by arsenic during the treatment of lichen planus. Nouv Presse Med. 10:1981;3073-3074.
93. Maier H., Schemper M., Ortel B., et al. Skin tumors in photochemotherapy for psoriasis A single-center follow-up of 496 patients . Dermatology. 193:1996;185-191.
94. Momtaz K., Fitzpatrick T.B. The benefits and risks of long-term PUVA photochemotherapy. Dermatol Clin. 16:1998;227-234.